Synthetic Biology Newsletter 2.0
This July 2011 issue of Synthetic Biology 2.0 looks at the work of the United States Presidential Bioethics Commission, the dominant discourse in the synthetic biology debate, vaccines as the first commercial applicaiton of synthetic biology, do-it-yourself biology, biosecurity, and biofiction where science and arts meet.
About the Author
Formerly European Commission, Directorate-General for Research and Technological Development, Directorate on Science, Economy and Society
Science and Technology Innovation Program
The Science and Technology Innovation Program (STIP) brings foresight to the frontier. Our experts explore emerging technologies through vital conversations, making science policy accessible to everyone. Read more